News & Insights
Stay up to date with the latest news,health insights, and updates from Ksimg consultants.
June 15, 2026
Zymeworks ADC ZW191 Shows Promise In Phase 1 Trial
VANCOUVER, British Columbia, June 15, 2026 – Zymeworks Inc. presented new Phase 1 clinical data for ZW191, its folate receptor
June 15, 2026
Canada Health IT Market Moves Toward Connected Care At e-Health26
HALIFAX, NS, June 15, 2026 – Canadian healthcare technology buyers are entering e-Health26 with a more demanding procurement agenda, according
June 15, 2026
EHA2026: Ascentage Pharma Shares New Trial Updates
ROCKVILLE, Md. and SUZHOU, China, June 15, 2026 – Ascentage Pharma Group International presented multiple clinical updates from its hematology
June 15, 2026
Symptoms Of Gallbladder Problems In Females: Signs, And Causes
Symptoms of gallbladder problems in females often include pain in the upper right abdomen, nausea, vomiting, bloating, pain after fatty
June 15, 2026
What Is Cystic Fibrosis In Babies? Symptoms, Diagnosis, And Treatment
What is cystic fibrosis in babies? Cystic fibrosis, often called CF, is a genetic condition that causes thick, sticky mucus
June 15, 2026
Can You Live Without A Pancreas? Life After Pancreas Removal
Can you live without a pancreas? Yes, you can live without a pancreas, but you will need lifelong medical care.
June 15, 2026
Autoimmune Pancreatitis: Symptoms, Causes, Diagnosis, And Treatment
Autoimmune pancreatitis is a rare type of long-term pancreas inflammation. It happens when the immune system appears to attack the
June 14, 2026
YourEra GLP 1 Analysis: How Long Does It Take To Show Results?
Weight loss treatment has changed quickly, especially with the rising demand for GLP-1 medications. Many adults now want a more
June 14, 2026
Keeps Hair Loss Treatment Analysis: Is It Better Than Regular Hair Products?
Hair loss can feel personal because it changes how a man sees himself every day. For some, it starts with
June 13, 2026
Sanofi’s Tzield Approved In US For Recently Diagnosed Stage 3 Type 1 Diabetes In Children
Sanofi has announced that the US Food and Drug Administration has granted accelerated approval for Tzield, also known as teplizumab-mzwv,